IN2013MU03428A - - Google Patents

Info

Publication number
IN2013MU03428A
IN2013MU03428A IN3428MU2013A IN2013MU03428A IN 2013MU03428 A IN2013MU03428 A IN 2013MU03428A IN 3428MU2013 A IN3428MU2013 A IN 3428MU2013A IN 2013MU03428 A IN2013MU03428 A IN 2013MU03428A
Authority
IN
India
Prior art keywords
fingolimod
salts
relates
dosage forms
oral dosage
Prior art date
Application number
Inventor
Girish Kumar Jain
Venkataramana Naidu
Saurabh Gupta
Prafulla Joshi
Anubhav Nagal
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3428MU2013 priority Critical patent/IN2013MU03428A/en
Publication of IN2013MU03428A publication Critical patent/IN2013MU03428A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to solid oral dosage forms comprising fingolimod or salts thereof. In particular, the present invention relates to solid oral dosage forms comprising fingolimod or salts thereof, and other pharmaceutically acceptable excipients. The invention further relates to method of treating multiple sclerosis by using the composition fingolimod or salts thereof.
IN3428MU2013 2013-10-30 2013-10-30 IN2013MU03428A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3428MU2013 IN2013MU03428A (en) 2013-10-30 2013-10-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3428MU2013 IN2013MU03428A (en) 2013-10-30 2013-10-30

Publications (1)

Publication Number Publication Date
IN2013MU03428A true IN2013MU03428A (en) 2015-07-17

Family

ID=54397484

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3428MU2013 IN2013MU03428A (en) 2013-10-30 2013-10-30

Country Status (1)

Country Link
IN (1) IN2013MU03428A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3143991A1 (en) * 2015-09-18 2017-03-22 Sanovel Ilac Sanayi ve Ticaret A.S. Fingolimod capsule composition
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3143991A1 (en) * 2015-09-18 2017-03-22 Sanovel Ilac Sanayi ve Ticaret A.S. Fingolimod capsule composition
WO2017046345A1 (en) * 2015-09-18 2017-03-23 Sanovel Ilac Sanayi Ve Ticaret A.S. Fingolimod capsule composition
WO2018178744A1 (en) * 2017-03-29 2018-10-04 Deva Holding Anonim Sirketi Stable formulations of fingolimod

Similar Documents

Publication Publication Date Title
MX2021011906A (en) Delayed release compositions of linaclotide.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
MX2018007704A (en) Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant.
MX2015010921A (en) Carbazole compounds useful as bromodomain inhibitors.
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
MX365939B (en) Nuclear transport modulators and uses thereof.
MX363347B (en) Salt of omecamtiv mecarbil and process for preparing salt.
IN2013MU03583A (en)
MX2016004741A (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent.
MX2016003823A (en) A selective inhibitor of phosphatidylinositol 3-kinase-gamma.
MX368903B (en) THERAPEUTIC COMPOUNDS and USES THEREOF.
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA201591507A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
PH12016502322A1 (en) Compounds and methods for preventing or treating malaria
MX2022014763A (en) Compositions of grapiprant and methods for using the same.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
MX373177B (en) TREATMENT METHODS FOR DYSKINESIA AND RELATED DISORDERS.
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
IN2013MU03428A (en)
IN2013MU03427A (en)
WO2015200768A3 (en) Pharmacologic treatments of menière's disease